ClinicalTrials.gg
Drug

Guadecitabine clinical trials

Also written SGI-110.

studies test it
31
open now
0
in phase 3
3
first study started
2011

How each study uses guadecitabine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Guadecitabine
24
DNMT inhibitor SGI-110
7
S110
7
SGI-110 (guadecitabine)
2

Development codes

SGI-110
22

Studies by the year they started

31 studies that test it; most in 2017 (8)

Studies that test guadecitabine, by start year
YearStudies
20111
20122
20131
20144
20154
20164
20178
20183
20191
20203

Who runs them

Industry 8 · Other 23

Astex Pharmaceuticals, Inc. (7) · University of Southern California (3) · M.D. Anderson Cancer Center (3) · National Cancer Institute (NCI) (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · Groupe Francophone des Myelodysplasies (2) · Italian Network for Tumor Biotherapy Foundation (2) · Memorial Sloan Kettering Cancer Center (1)

Often tested with

Tested in the same studies.

Carboplatin (2) · Mocetinostat (1) · Decitabine and cedazuridine drug combination (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test guadecitabine.

Studies

Open first, then newest update. How each study uses guadecitabine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test guadecitabine →

Given beside what is tested · 2 — guadecitabine is usual care or a partner of the new treatment

Codes

What other systems call guadecitabine · ClinicalTrials.gg INT006268

  • MeSH (NLM) C580831guadecitabineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2KT4YN1DP7GUADECITABINEConfirmed FDA, NLM, Wikidata
  • Wikidata Q27254880guadecitabineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C95209GuadecitabineOne source FDA
  • DrugBank DB11918One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.